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Introduction 
 
Stepped wedge trials are cluster randomised trials in which clusters are followed longitudinally, with 
different clusters randomised to cross from the control condition to the active intervention 
condition at different times.1 This experimental approach mirrors the natural process of 
implementing an intervention over many sites, and is often associated with situations where a policy 
decision has already been made to roll out an intervention.2 Stepped wedge trials are increasingly 
popular, with systematic reviews showing an exponential growth in the number of published reports 
and registered protocols.2–7 A new CONSORT extension covering stepped wedge trials has been 
produced.8,9 Methodologists have also embraced the topic: in the pages of the Journal of Clinical 
Epidemiology a vigorous debate blossomed over the relative efficiency of stepped wedge and more 
traditional designs.2,10–21 This discussion illustrated, above all, that precision is key in discussing the 
unique features of stepped wedge trials: the devil is in the detail. 
 
But the general definition of a stepped wedge trial given above hides substantial variation in their 
design in practice, according to the plan for recruitment and the flow of individual participants 
through the study.22 One common subtype involves the continuous recruitment of participants from 
each cluster over the same interval of time, with different clusters crossing over to the intervention 
at different points along this interval. For example, in their stepped wedge trial of placental growth 
factor testing to assess women with suspected pre-eclampsia, Duhig and colleagues recruited 
participants continuously over a 16-month interval, as and when women presented with suspected 
pre-eclampsia at one of 11 participating maternity units.23 This is in sharp contrast to the way data 
are collected for a trial such as the Devon Active Villages Evaluation (DAVE) by Solomon and 
colleagues, in which participants were sampled from village communities in a series of discrete 
cross-sectional surveys.24 
 
The literature on stepped wedge trials has tended not to differentiate too closely between 
continuous recruitment and discrete sampling. Here we argue that a deeper understanding of the 
unique features of continuous recruitment processes will help researchers to identify risks of 
contamination and to make more appropriate design and analysis choices. 
 
Continuous recruitment with short exposure 
 
If participants remained exposed to a potential intervention in the cluster for a long period following 
their recruitment, then we could follow individuals longitudinally to see how their outcomes change 
when the cluster crosses from the control to the intervention. But more commonly participants who 
are recruited continuously are exposed only briefly, and each participant’s primary outcome is 
assessed just once: either as a control or an intervention participant. In the typology of Copas and 
colleagues this is known as a continuous recruitment short exposure design.22 
 
For example, Poldervaart and colleagues evaluated a policy which promoted the use of a scoring 
system to guide clinical decisions for patients with acute chest pain on arrival at hospital emergency 
departments.25 Nine hospitals were randomised to change over to the intervention at staggered 
intervals over a recruitment period which ran from July 2013 to August 2014. The primary outcome, 
assessed for each individual participant, was a major cardiac event within six weeks of presentation 
at the hospital. Median length of stay in the emergency department (exposure) was 4 hours.26 
 
A note on our terminology: the “exposure” period refers to the interval over which a participant is 
exposed to the possibility of receiving the active intervention if it were introduced at a cluster – 
either exposed directly, because the intervention is delivered at cluster level, or indirectly, through 
contact with other individuals in the same cluster who receive the intervention. 
 
It is worth noting that in a continuous recruitment short exposure design the outcome may be 
assessed some considerable time after the individual was recruited. The first ever stepped wedge 
trial, which evaluated the effectiveness of adding Hepatitis B virus (HBV) vaccination to a routine 
programme of childhood vaccination in The Gambia, provides an extreme example. Clusters were 
distinct geographical regions defined by the locations of 17 health centres.  The schedule of 
vaccinations lasted for 9 months, but the window of opportunity for a child to be recruited into the 
trial, and for vaccination of a child to begin, was short (the first month after birth). If a child did not 
receive HBV vaccination at the first vaccination visit they did not receive it at any subsequent visit. 
The primary outcome of hepatocellular carcinoma was not determined until 30 years later.27 Even 
though participants might have lived in the same region of The Gambia for all of those 30 years, their 
direct “exposure” was short (one month), because of the short window of opportunity for starting 
HBV vaccination. Thus participants could reliably be labelled as “control” or “intervention” 
depending on whether they were born before or after the cross-over in their cluster. (The question 
of indirect exposure is less clear: all participants might have benefitted from some degree of herd 
immunity over the decades which followed the introduction of the HBV vaccination programme to 
their communities.) 
 
Contamination within a cluster 
 
In many trials with continuous recruitment it is not possible to cross seamlessly and instantaneously 
from recruitment under the control condition to recruitment under the active intervention 
condition. In a cluster in the process of crossing over from the control to the intervention, some 
participants may experience a mixture of the two, or something intermediate. The CONSORT 
extension to stepped wedge trials warns of the dangers of this kind of “contamination” of 
treatments.8 To understand these issues in more detail (the devil is in the detail!) we must map out 
the timeline for cross-over in a cluster. We start by defining terms, and then give examples.  
 In a stepped wedge trial the cross-over is unidirectional – from the control condition (usually routine 
care) to the active intervention, but never in reverse. With this kind of unidirectional cross-over 
there are (up to) four key phases in a cluster: (1) a period of recruitment under the control condition, 
(2) a period allowing for the “closure” of the control recruitment period (we elaborate on this 
below), (3) a period of implementation of the active intervention; (4) a period of recruitment under 
the active intervention. 
 
The closure period (2) should be long enough that any participants who were recruited before the 
closure period begins will either have had their outcomes assessed, or are no longer exposed by the 
end of the closure period. The closure period is therefore the shorter of the exposure period and the 
time from recruitment to outcome measurement. The implementation period (3) should be long 
enough for the intervention to be set up within a cluster and operating at full strength. 
 
The closure period is often negligible (or at least short) because exposure is short. In Poldervaart’s 
trial the amount of time spent by each participant in the emergency department was a tiny fraction 
of the overall recruitment period. But this is not always the case. Berdal and colleagues reported 
results from a stepped wedge trial of an experimental rehabilitation programme for patients with 
rheumatic diseases who were admitted to rehabilitation centres in Norway.28,29 The comparator was 
traditional rehabilitation, whose duration could vary between 1 and 4 weeks, and outcomes were 
not assessed until after a participant had been discharged. The closure period required for this trial 
would have been 4 weeks – long enough to ensure that all participants recruited under the control 
condition had left the centre before the implementation of the intervention began. 
 
The implementation period is also often assumed to be negligible. This is sometimes achieved in 
practice by delivering training materials to a cluster before the scheduled switch. In Berdal’s trial, for 
example, a team of research intervention facilitators visited each centre with study materials 
2 weeks before the cross-over was due. It is vital to understand whether intervention materials pre-
delivered in this way could be accessed by health professionals or participants in a cluster before the 
official cross-over. If they can, then the implementation period (as we define it here) must be 
considered to begin from this point. Other trials have included explicit implementation periods in 
their design: Peden and colleagues allowed a 5-week interval for their quality improvement 
intervention to be introduced in hospitals performing emergency laparotomies.30 
 
Avoiding contamination 
 
To avoid contamination we propose the following as a standard of good practice: that all 
recruitment be suspended for the combined duration of the closure period and implementation 
period, or at least that these participants be excluded from the primary comparison of control and 
intervention. This principle was followed in Peden’s trial, for example. The combined closure and 
implementation period is sometimes referred to as a “transition period” between recruitment under 
the control and intervention conditions.1 
 
The closure period ensures that outcomes of “control” participants are not contaminated by the 
intervention, even while it is being set up. The implementation period ensures that “intervention” 
participants are never receiving a less-than-full-strength intervention – i.e. are not contaminated by 
a weaker form of the intervention. 
 
Diagrams 
 
The CONSORT extension recommends diagrams as a tool for understanding the risk of 
contamination in stepped wedge designs.8 If the phases of control recruitment, closure, 
implementation, and intervention recruitment in a cluster are non-overlapping (as we recommend) 
they can be shown schematically as a sequence of differently shaded or coloured bars running along 
a time axis. The number of people recruited under the control (or intervention) condition in a given 
cluster will be the product of the recruitment rate and the length of the control (or intervention) 
recruitment period. In some situations, as noted above, the closure or implementation period may 
be assumed to be negligible, meaning that a cluster can cross seamlessly from control recruitment to 
intervention recruitment. When such an assumption is made it should be justified. If a cluster is not 
required to include any control participants then a closure period is unnecessary, and the cluster can 
begin in the implementation or intervention recruitment phase. 
 
Figure 1 illustrates such a diagram for a complete stepped wedge trial design with clusters 
randomised to four different sequences. The example is a traditional stepped wedge, with cross-
over times regularly spaced across sequences, and all clusters starting in the control condition and 
finishing in the intervention condition. When recruitment is a continuous time process it is worth 
bearing in mind that we have the freedom to choose cross-over times anywhere along the 
continuous time-line, and the time selected for one cluster to cross over need not have any 
significance in another cluster. Nor is there any particular reason for the end of one transition to 
align with the beginning of another. As long as we have allowed sufficient time for closure and 
implementation we can usefully begin recruitment again. Observe how different this is to the way 
time is conceived in the classic Hussey and Hughes model for stepped wedge trials, where time 
consists of discrete periods divided by cluster cross-overs.31 
 
What every stepped wedge trial does require is a fine degree of control over which clusters make 
the transition to the active intervention and when. This is one of their enduring challenges. 
 
Time as a continuous variable 
 
The analysis of any stepped wedge trial must adjust appropriately for time, which will generally be 
confounded with treatment (as time goes on more and more clusters are in the intervention 
condition). Adjusting for time as a discrete factor, as in the Hussey and Hughes model, seems an 
inadequate approach to the analysis of a stepped wedge trial with continuous recruitment. An 
alternative might be to model time as a continuous variable with a linear or smoothly varying effect 
on outcome, rather like an interrupted time series analysis.32,33 This kind of analysis choice feeds 
back to design and sample size calculation: the sample size needed for an analysis adjusting for a 
continuous, linear effect of time will not be the same as that needed if the adjustment is for discrete 
time.34 
 
The Hussey and Hughes model also assumes that the intracluster correlation – the correlation 
between the outcomes of two individuals from the same cluster – is the same for any pair of 
individuals. This is known as complete exchangeability. Other authors have attempted to generalise 
this to allow the intracluster correlation to grow weaker over time, while still treating time as 
discrete.35–37 In these discrete-time models for intracluster correlation there is still exchangeability 
within a given time period. Again, as soon as we view recruitment as continuous this approach 
becomes inadequate: two individuals recruited at either end of the “same” period will have much 
less to do with each other than two individuals recruited just on either side of a “division” between 
periods. An approach where the intracluster correlation decays as a continuous function of the time 
separating the two individuals may be a better alternative.32 Again, this impacts on design as well as 
analysis. 
 
Terminology 
 
Copas and colleagues identified three distinct subtypes of stepped wedge trial: continuous 
recruitment short exposure designs, “open cohort” designs like the DAVE trial with its repeated 
survey samples, and “closed cohort” designs which follow the same individuals longitudinally.22 
Other authors blur the boundaries of open cohort and continuous recruitment designs to form a 
single category of “cross-sectional” stepped wedge trials, in which each participant is only assessed 
once.1,21 This usage is misleading: “cross-sectional” conjures an image of a series of cross-sectional 
slices through time – something quite different to a continuous recruitment process. We suggest 
that the term “repeated cross-section” be restricted to trials involving discrete surveys of a cluster 
population. We prefer to use the term “continuous recruitment” for what it is. “Continuous 
recruitment short exposure” is a more specific term, but as noted above the exposure need not 
always be short. 
 
Conclusions 
 
Continuous recruitment stepped wedge trials are likely to continue to be popular with researchers. 
Depending on how such a trial is conducted there can be a risk of contamination within a cluster, 
though some care and thought can help to address this. A diagram can help us to visualise the design 
and judge the risk more clearly. 
 
We have proposed a diagram describing the timeline of recruitment and transition as planned in 
advance of a trial. In reality, individual clusters may deviate from the planned timeline. There could 
also be systematic deviations if, for example, the intervention takes longer to implement than 
anticipated. By careful monitoring of trial conduct it may be possible to report the actual timelines 
experienced by clusters, as well as those planned, and to consider the consequent risks of 
contamination. Exactly what we mean in general by “intention-to-treat” or “as treated” analyses of a 
stepped wedge trial may be open to debate,8 but with clarity of reporting and reflection on the risks 
of bias we can start to explore such alternatives.  
 
Though framed in terms of stepped wedge trials, the ideas presented here apply equally to simpler 
designs for cluster randomised trials with continuous recruitment, such as a parallel groups design 
with a baseline period. We have not touched on the question of optimal design: how should a 
schedule be chosen for transition and recruitment to minimise the total number of clusters or 
participants? This is a fertile area for future research. Incorporating time as a continuous variable in 
the analysis of stepped wedge trials is also likely to be the focus of ongoing work. Sample size 
calculation and other design tools need development and expansion in parallel. A continuous 
timescale gives a stepped wedge trial something of the feel of an interrupted time series study, 
albeit a randomised one, and perhaps there is more to be learned about the analysis of continuous 
recruitment stepped wedge trials from a cross-fertilisation with the interrupted time series 
literature. 
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Figure 1. Schematic representation of a stepped wedge trial with continuous recruitment, 
distinguishing four phases in each cluster: recruitment under the control condition, closure of the 
control recruitment period, implementation of the active intervention, and recruitment under the 
active intervention condition. 
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